New York, New York–(Newsfile Corp. – January 22, 2025) – FOR WHAT: Rosen Law Firm, an international investor rights law firm, reminds purchasers of Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between May 6, 2021 and November 6, 2024, both dates inclusive ( the “Class Period”), important Deadline of January 27, 2025 for principal applicant.
AND THEN: If you purchased Dentsply Sirona common stock during the Class Period, you may be entitled to compensation without payment of any fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the court no later than January 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a proven track record in leadership roles. Often, companies issuing reviews do not have significant experience, resources, or peer recognition. Many of these firms do not actually defend securities class actions, but are simply intermediaries that refer clients or partner with law firms that actually litigate cases. Be wise in choosing a lawyer. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. The Rosen Law Firm obtained the largest securities class action settlement against a Chinese company at the time. Rosen Law Firm Ranked #1 by ISS Securities Class Action (WA:) Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of the Plaintiffs Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose material facts necessary for the statements made, in light of the circumstances under which they were made. , are neither false nor misleading. In truth, Byte aligners have been causing serious patient injuries since at least May 2021, as revealed in overdue injury reports that Dentsply Sirona filed with the U.S. Food and Drug Administration (“FDA”) during of the year 2024. At least part of the problem was that customer service employees and supervising dentists were incentivized to enroll contraindicated patients who had other dental problems that should have made them ineligible for Byte treatment. As a result, Defendants’ positive statements regarding Byte’s customer experience and the extensive network of dentists supervising and controlling each customer’s treatment were materially misleading and/or lacked a reasonable basis. Additionally, Dentsply Sirona concealed the fact that its high conversion rates were due to marketing incentives to recruit contraindicated patients. When the true details were leaked to the market, the lawsuit claims, investors suffered damages.
To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No classes have been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent member of the group and do nothing at this point. An investor’s ability to participate in any potential future recovery is not dependent on its status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:) : https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
——————————-
Contact details:
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238134
